photonamic GmbH & Co. KG   Report issue

For profit Phase 2
Founded: Wedel Germany (2002)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2010
NCT01110954
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

photonamic GmbH & Co. KG

Active Ingredients

Drugs in Phase 2 Trials (2)

aminolevulinic acid (levulan) (5 trials)

pd l 506 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Glioblastoma (Phase 2)

Onychomycosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 2